Literature DB >> 31614359

Three Novel Aberrations Involving PLAG1 Leading to Lipoblastoma in Three Different Patients: High Amplification, Partial Deletion, and a Unique Complex Rearrangement.

Guoliang Wang, Miguel A Guzman, Jacqueline R Batanian.   

Abstract

Lipoblastoma is a rare benign neoplasm with overlapping histology with other lipomatous tumors. Genetic aberrations including translocations of 8q and splitting of the PLAG1 probe leading to "promoter swapping" and gains of chromosome 8 or PLAG1 foci have been described in lipoblastoma. Here, we report 3 lipoblastomas revealing novel genetic aberrations involving PLAG1: a high level of PLAG1 amplification up to 50 copies in a 4-year-old girl with recurrence of a right flank mass, a partial deletion of PLAG1 with the flanking junction breakpoints involving the 3'PLAG1 and 5'HAS2 genes in a 17-month-old boy with a retroperitoneal mass, and an insertion of 2q31 into 8q11.2 and translocation of 8q to 2q with the latter translocated onto 12q leading to separation of the PLAG1 FISH probe in a 5-year-old girl with a left back mass. Our novel cytogenetic findings further expand the mechanisms of PLAG1 transcriptional upregulation in lipoblastoma pathogenesis.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  <italic>PLAG1</italic>; Array CGH; Chromosome rearrangement; Cytogenetics; FISH; Lipoblastoma

Mesh:

Substances:

Year:  2019        PMID: 31614359     DOI: 10.1159/000503158

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  2 in total

Review 1.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

2.  A large retroperitoneal lipoblastoma as an incidental finding: a case report.

Authors:  Elena Gerhard-Hartmann; Verena Wiegering; Clemens Benoit; Thomas Meyer; Andreas Rosenwald; Katja Maurus; Karen Ernestus
Journal:  BMC Pediatr       Date:  2021-04-04       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.